Pure Global

HEMAX CellLyse Lyse-HX3 - Indonesia BPOM Medical Device Registration

HEMAX CellLyse Lyse-HX3 is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20208912167. The device is manufactured by B&E BIO-TECHNOLOGY CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. WHIRA PITOE USAHABERSAMA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
HEMAX CellLyse Lyse-HX3
Analysis ID: AKL 20208912167

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. WHIRA PITOE USAHABERSAMA

AR Address

RUKO BUARAN PERSADA NO. 10, JL. JEND.POL.SOEKAMTO RT.008/06,KEL.DUREN SAWIT

Registration Date

Sep 05, 2022

Expiry Date

May 12, 2027

Product Type

Hematological Reagents

Red cell lysing reagent.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing